| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―19 |
Mortality in patients with type 2 diabetes mellitus following coronavirus infection during the acute phase and long-term period |
D. R. Sarkisian, J. A. Kovaleva, A. A. Glazkov, E. P. Kakorina, I. V. Misnikova |
| 2 |
[GO] |
2024―Nov―21 |
Retrospective Analysis of the Characteristics of the Post-COVID Period in Patients with Type 2 Diabetes, Infected During Different Variant-Associated Periods of COVID-19 |
S. A. Altynbekova, V. V. Fadeev, Z. Abilayuly, S. V. Bolshakova |
| 3 |
[GO] |
2024―May―11 |
The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus |
T. N. Markova, M. S. Stas |
| 4 |
[GO] |
2024―Jan―10 |
Glucose metabolism disorders associated with COVID-19: clinical and morphological study |
T. L. Karonova, A. A. Mikhailova, D. I. Lagutina, O. M. Vorobeva, D. O. Grigoreva, K. A. Sterkhova, et al. (+5) V. A. Malko, A. G. Mikheeva, A. T. Chernikova, L. B. Mitrofanova, E. V. Shlyakhto |
| 5 |
[GO] |
2024―Jan―10 |
Efficacy and safety of glucagon-like peptide-1 receptor agonists therapy initiation in patients with type 2 diabetes hospitalized with coronavirus infection |
T. N. Markova, M. A. Lysenko, M. S. Stas, A. A. Anchutina |
| 6 |
[GO] |
2023―Sep―01 |
Organization of outpatient care for patients with diabetes mellitus in the context of the COVID-19 pandemic using telemedicine technologies |
V. V. Chichkova, M. A. Shapovalova, M. A. Chichkova, M. B. Antsiferov |
| 7 |
[GO] |
2023―Jul―18 |
Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage |
T. A. Nekrasova, L. G. Strongin, D. V. Belikina, E. S. Malysheva, A. A. Nekrasov |
| 8 |
[GO] |
2023―Feb―09 |
Relationship between severe acute respiratory syndrome coronavirus 2 and diabetes mellitus (review) |
G. M. Artykbaeva, T. S. Saatov |
| 9 |
[GO] |
2022―Dec―02 |
Сarbohydrate metabolism disorders and their outcomes in the long-term period in hospitalized patients with COVID-19 |
V. V. Salukhov, A. A. Minakov, T. G. Sharypova, A. A. Kononova, V. A. Surkhaeva |
| 10 |
[GO] |
2022―Dec―02 |
Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020-2022 years: Russian nationwide retrospective study |
N. G. Mokrysheva, M. V. Shestakova, O. K. Vikulova, A. R. Elfimova, M. A. Isakov, N. A. Gins, et al. (+2) A. A. Deviatkin, I. I. Dedov |
| 11 |
[GO] |
2022―Oct―04 |
Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia |
F. A. Khaydarova, A. V. Alieva, D. M. Berdikulova, N. U. Alimova, D. Z. Khalilova, I. M. Tojieva |
| 12 |
[GO] |
2022―Mar―23 |
Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists |
I. I. Dedov, N. G. Mokrysheva, M. Vladimirovna Shestakova, T. V. Nikonova, A. Yu. Mayorov, G. R. Galstyan, et al. (+20) M. Sh. Shamhalova, V. O. Barysheva, A. S. Ametov, M. B. Antsiferov, A. Yu. Babenko, T. P. Bardymova, F. V. Valeeva, A. A. Vachugova, E. N. Grineva, T. Yu. Demidova, T. P. Kiseleva, M. A. Kunicyna, T. N. Markova, A. M. Mkrtumyan, N. A. Petunina, L. A. Ruyatkina, V. V. Saluhov, L. A. Suplotova, E. L. Hadarceva, Yu. Sh. Halimov |
| 13 |
[GO] |
2022―Mar―23 |
Impact of COVID-19 infection on the development of type 1 diabetes mellitus in children and adolescents |
F. A. Khaydarova, N. U. Alimova, A. V. Alieva, A. S. Sadykova, M. D. Aripova |
| 14 |
[GO] |
2021―Sep―30 |
Clinical characteristics of patients with COVID-19 depending on the treatment received and the presence of type 2 diabetes mellitus |
K. G. Lobanova, T. Y. Demidova, S. N. Perekhodov, M. B. Antsiferov |
| 15 |
[GO] |
2021―Sep―30 |
Prevalence of carbohydrate metabolism disorders in patients with new coronavirus infection |
T. N. Markova, M. A. Lysenko, A. A. Ivanova, E. S. Pavlova, A. A. Ponomareva, V. V. Chibisova, et al. (+3) T. K. Isaev, D. O. Sinyavkin, A. M. Mkrtumyan |
| 16 |
[GO] |
2021―Feb―15 |
Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease |
E. M. Zeltyn-Abramov, M. A. Lysenko, N. F. Frolova, T. N. Markova, N. I. Belavina, N. N. Klochkova, et al. (+3) S. V. Kondrashkina, R. T. Iskhakov, A. I. Ushakova |
| 17 |
[GO] |
2021―Feb―15 |
High level of glycated hemoglobin (HbA1c) in patients with COVID-19 is a marker of the severity of the infection but not an indicator of previous diabetes mellitus |
M. V. Shestakova, I. V. Kononenko, Z. A. Kalmykova, A. V. Zheleznyakova, N. G. Mokrysheva |
| 18 |
[GO] |
2020―Aug―10 |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
Z. A. Kalmykova, I. V. Kononenko, I. A. Sklyanik, M. V. Shestakova, N. G. Mokrysheva |
| 19 |
[GO] |
2020―Aug―10 |
COVID-19 and kidneys |
M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova |
| 20 |
[GO] |
2020―Aug―10 |
The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus |
O. K. Vikulova, Zamira Zuraeva, L. V. Nikankina, M. V. Shestakova |
| 21 |
[GO] |
2020―Jun―27 |
Course and treatment of diabetes mellitus in the context of COVID-19 |
Marina V. Shestakova, Natalya G. Mokrysheva, Ivan I. Dedov |
